Bone Marrow Transplantation (Transplantation, Bone Marrow)

Subscribe to Selected New Research on Bone Marrow Transplantation

11076 relevant articles (983 outcomes, 831 trials/studies) found for this Therapy

Description: The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION.

Also Known As:

Transplantation, Bone Marrow; Bone Marrow Grafting; Bone Marrow Cell Transplantation; Grafting, Bone Marrow; Transplantation, Bone Marrow Cell

Relationship Network

Therapy Context: Research Results

Operative Surgical Procedures: 4

Transplantation: 36585

Tissue Transplantation: 195

Bone Marrow Transplantation: 11076

Experts

1.	Au, W Y: 12 articles (08/2007 - 11/2000)
2.	Gluckman, Eliane: 12 articles (05/2007 - 04/2002)
3.	Locatelli, F: 11 articles (07/2007 - 03/2000)
4.	Kodera, Y: 10 articles (02/2006 - 08/2000)
5.	Lie, A K W: 9 articles (08/2007 - 01/2002)
6.	Asaka, M: 9 articles (12/2004 - 06/2000)
7.	Bacigalupo, A: 9 articles (01/2004 - 01/2000)
8.	Uderzo, C: 9 articles (11/2003 - 02/2000)
9.	Mori, A: 9 articles (02/2003 - 06/2000)
10.	Takatsuka, H: 9 articles (06/2002 - 04/2000)

Related Diseases

1.	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/01/1992 - "In the attempt to evaluate the role of Autologous and Allogeneic Bone Marrow Transplantation, we have retrospectively analyzed 159 patients with Acute Myeloid Leukemia in first complete remission treated in our Unit, most of whom were referred from other Institutions" 02/01/1992 - "New approaches are needed to increase the cure rate substantially, and autologous bone marrow transplantation appears to be the most promising treatment modality in acute myeloid leukemia" 01/01/1992 - "Is allogeneic bone marrow transplantation the best treatment for young adult patients with acute myeloid leukemia in first complete remission" 01/01/1985 - "It is widely assumed that most patients with acute nonlymphocytic leukemia (ANLL) are less than 60 years old, that greater than 50% of all patients can now achieve a complete remission (CR), and that bone marrow transplantation (BMT) represents a significant therapeutic breakthrough in this disease" 05/01/2004 - "On the basis of observations from dog models and human studies, we hypothesized that a low-dose (550 cGy), single-exposure total body irradiation (TBI)-based regimen would result in improved survival when given to adult patients with acute myelogenous leukemia (AML) who were undergoing unrelated donor bone marrow transplantation in complete remission (CR)" Get all the results and reference details, order at left...
2.	Leukemia 03/01/1997 - "Allogenic bone marrow transplantation is the treatment of choice in chronic granulocyte leukemia patients, while the best results are achieved when it is performed in the chronic phase of the illness" 04/01/1994 - "Although allogeneic bone marrow transplantation has been shown to be a highly effective treatment for acute and chronic leukemia, leukemic relapse remains a significant problem" 04/01/1993 - "The role of total body irradiation (TBI) for allogeneic bone marrow transplantation (BMT) for acute leukemia in first complete remission was reevaluated in this study" 12/01/2007 - "Proportions of cells expressing CD38-/CD34+, CD38+/CD34+, CD19+/CD34+, or CD13,33+/CD34+ in the regenerating bone marrows during complete remission of acute leukemia or after bone marrow transplantation]" 12/01/2006 - "He was considered in complete remission for leukemia after allogenic bone marrow transplantation" Get all the results and reference details, order at left...
3.	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/01/1993 - "In a retrospective multicentre study, we analyzed 184 consecutive patients who underwent bone marrow transplantation (BMT) from identical siblings for adult acute lymphoblastic leukemia in first complete remission between March 1980 and May 1989" 10/01/2006 - "A 42-year-old woman was referred to us for the treatment of relapsed Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL), which had been maintained in complete remission for seven years after an allogeneic bone marrow transplantation (allo-BMT) from an unrelated donor" 07/01/2005 - "Donor leukocyte infusion (DLI) alone has very limited efficacy for patients with acute lymphoblastic leukemia (ALL) who have relapsed after allogeneic bone marrow transplantation (BMT)" 02/01/2004 - "The role of allogeneic bone marrow transplantation (alloBMT) in adults with acute lymphoblastic leukemia (ALL) in first complete remission (CR1) remains controversial" 02/01/2004 - "The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor vs no donor comparison." Get all the results and reference details, order at left...
4.	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/01/2000 - "BACKGROUND AND OBJECTIVE: For purposes of therapeutic decision making, we used quantitative polymerase chain reaction (PCR) for molecular follow-up of 55 patients with chronic myeloid leukemia (CML) in complete remission (CR) after allogeneic bone marrow transplantation (BMT) from HLA compatible donors" 02/01/1999 - "PURPOSE: Donor lymphocyte infusion (DLI) can restore complete remission in patients with chronic myelogenous leukemia (CML) who have relapsed after T-cell-depleted (TCD) allogeneic bone marrow transplantation (BMT)" 11/01/1998 - "Donor leukocyte infusions (DLI) have turned out to be an efficient way to re-establish complete remission (CR) in chronic myeloid leukemia (CML) patients relapsing after allogeneic bone marrow transplantation (BMT)" 03/01/1998 - "The authors report the case of a chronic myeloid leukemia (CML) patient submitted to allogenic bone marrow transplantation, who had probably never entered complete remission" 12/01/1995 - "Donor lymphocyte infusions can reinduce complete remission in the majority of patients with chronic myelogenous leukemia (CML) who relapse into chronic phase after allogeneic bone marrow transplantation (BMT)" Get all the results and reference details, order at left...
5.	Neoplasms (Cancer) 10/26/1985 - "This study shows that autologous bone marrow transplantation is feasible and can produce a high proportion of complete remission in otherwise resistant tumors" 01/01/2004 - "Advances in combination chemotherapy, radiation therapy, surgery, and bone marrow transplantation have resulted in markedly improved survival rates for many children with cancer" 03/01/1993 - "The use of chemotherapeutic drugs in combination with bone marrow transplantation to treat cancer patients has markedly improved the disease-free survival and cure rate" 05/01/1989 - "These treatments were well tolerated since out of 19 mice with complete tumor remission only 4 required bone marrow transplantation and 17 were in good health for 6-12 mo of observation" 01/01/2000 - "The principal objective of detecting low levels of tumor cells is to obtain more information about the efficacy of the treatment in order to: 1) design adapted post-remission protocols for high risk patients, 2) predict relapses previous to the clinical manifestations, 3) study the quality of stem cells harvested for autologous bone marrow transplantation." Get all the results and reference details, order at left...
931 Diseases and 11076 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Cyclophosphamide (Cytoxan)
2.	Cytarabine (Cytosar-U)
3.	Etoposide (VP 16)
4.	Melphalan (Alkeran)
5.	Busulfan (Busulfex)
6.	Antigens
7.	Interferon-alpha (Interferon Alfa)
8.	Cyclosporine (Ciclosporin)
9.	Interleukin-2 (IL2)
10.	perfosfamide
743 Drugs and Important Bio-Agents and 2783 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Transplants (Transplant)
3.	Transplantation (Transplant Recipients)
4.	Immunotherapy
5.	Autologous Transplantation (Autograft)
111 Therapies and Procedures and 2415 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>